Globe iconLogin iconRecap iconSearch iconTickets icon

Indians' Arias suspended for Nandrolone

Cleveland's 24th-round pick to sit 56 games after positive drug test
August 15, 2016

NEW YORK -- Indians Minor Leaguer Skylar Arias was suspended on Monday after testing positive for a steroid.

The Office of the Commissioner of Baseball said Skylar Arias received a 56-game suspension without pay after testing positive for Nandrolone, a performance-enhancing substance in violation of the Minor League Drug Prevention and Treatment Program.

The suspension of Arias is effective immediately.

Arias, 19, was the Indians' 24th-round pick in this year's Draft out of Tallahassee Community College, where he had completed his freshman year. He signed with the Tribe on June 20 and was 1-1 with a 3.72 ERA and 20 strikeouts in 19 1/3 innings over 11 relief outings this season with the Rookie-level Arizona League Indians. The southpaw has issued just three walks and was holding batters to a .234 average.

At Tallahassee, Arias had 89 strikeouts and 19 walks this past year, averaging nearly 11 strikeouts per nine.

Nandrolone, commonly sold as Deca-Durabolin, is an anabolic steroid used to promote muscle growth, bone density and red blood cell production. It's considered a Schedule III controlled substance.

Major League Baseball has issued 68 suspensions to 67 players this year for violations of the Minor League drug program.

Danny Wild is an editor for Follow his MLBlog column, Minoring in Twitter.